...
首页> 外文期刊>Drugs in R&D >A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI
【24h】

A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI

机译:药物诱导唾液腺功能不全,口干症和主观唾液的指南:由世界口腔医学研讨会VI赞助的系统评价

获取原文

摘要

BackgroundMedication-induced salivary gland dysfunction (MISGD), xerostomia (sensation of oral dryness), and subjective sialorrhea cause significant morbidity and impair quality of life. However, no evidence-based lists of the medications that cause these disorders exist. ObjectiveOur objective was to compile a list of medications affecting salivary gland function and inducing xerostomia or subjective sialorrhea. Data SourcesElectronic databases were searched for relevant articles published until June 2013. Of 3867 screened records, 269 had an acceptable degree of relevance, quality of methodology, and strength of evidence. We found 56 chemical substances with a higher level of evidence and 50 with a moderate level of evidence of causing the above-mentioned disorders. At the first level of the Anatomical Therapeutic Chemical (ATC) classification system, 9 of 14 anatomical groups were represented, mainly the alimentary, cardiovascular, genitourinary, nervous, and respiratory systems. Management strategies include substitution or discontinuation of medications whenever possible, oral or systemic therapy with sialogogues, administration of saliva substitutes, and use of electro-stimulating devices. LimitationsWhile xerostomia was a commonly reported outcome, objectively measured salivary flow rate was rarely reported. Moreover, xerostomia was mostly assessed as an adverse effect rather than the primary outcome of medication use. This study may not include some medications that could cause xerostomia when administered in conjunction with others or for which xerostomia as an adverse reaction has not been reported in the literature or was not detected in our search. ConclusionsWe compiled a comprehensive list of medications with documented effects on salivary gland function or symptoms that may assist practitioners in assessing patients who complain of dry mouth while taking medications. The list may also prove useful in helping practitioners anticipate adverse effects and consider alternative medications.
机译:背景药物引起的唾液腺功能障碍(MISGD),口干症(口腔干燥感)和主观性腹泻会导致严重的发病率并损害生活质量。但是,不存在导致这些疾病的药物的循证清单。目的我们的目的是编制一系列影响唾液腺功能,诱发口干或主观唾液的药物。数据来源检索电子数据库中2013年6月之前发表的相关文章。在3867篇筛选记录中,有269篇相关程度,方法学质量和证据强度均在可接受范围内。我们发现56种化学物质具有较高的证据水平,而50种化学物质具有中等水平的证据可导致上述疾病。在解剖治疗化学(ATC)分类系统的第一级,代表了14个解剖学组中的9个,主要是饮食,心血管,泌尿生殖,神经和呼吸系统。管理策略包括在可能的情况下替代或停用药物,采用口语的口服或全身治疗,唾液替代品的管理以及电刺激设备的使用。局限性虽然口干症是一个普遍报道的结局,但很少有客观测量唾液流速的报道。此外,口干症大多被评估为不良反应,而不是药物使用的主要结果。这项研究可能不包括与其他药物合用时可能引起口干症的药物,或者文献中未报道或在我们的搜索中未发现针对口干症的不良反应。结论我们汇总了对唾液腺功能或症状有文献记载作用的药物清单,这些药物清单可能有助于从业人员评估服药期间口干的患者。该清单也可能有助于帮助从业者预测不良反应并考虑替代药物。

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号